Stock listing
NASDAQ:PHAS PhaseBio Pharmaceuticals Inc Stock
Follow PhaseBio Pharmaceuticals Inc into a list and get an email when it puts out news.
Delisted NASDAQ:PHAS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PHAS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
PhaseBio Pharmaceuticals Inc on 6ix
- Decks
- 19 decks · latest Aug 12, 2022
Where PhaseBio Pharmaceuticals Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PHAS · This page · Delisted | NASDAQ | United States | USD |
| OTC:PHASQ · Delisted | OTC | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2022) | Investor deck | 32 slides | Aug 12, 2022 |
| Q1 2022 Earnings Presentation | Earnings | 32 slides | May 16, 2022 |
| Q4 2021 Earnings Presentation | Earnings | 31 slides | Mar 24, 2022 |
| Technical Presentation (November 2021) | Technical | 43 slides | Nov 15, 2021 |
| Investor Presentation (November 2021) | Investor deck | 35 slides | Nov 10, 2021 |
| Investor Presentation (August 2021) | Investor deck | 34 slides | Aug 12, 2021 |
| Investor Presentation (May 2021) | Investor deck | 30 slides | May 13, 2021 |
| Investor Day (March 2021) | Investor day | 77 slides | Mar 15, 2021 |
| Investor Presentation (November 2020) | Investor deck | 28 slides | Nov 12, 2020 |
| Investor Presentation (August 2020) | Investor deck | 30 slides | Aug 11, 2020 |
All 19 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (May 2020) | Investor deck | 28 slides | May 12, 2020 |
| Investor Presentation (March 2020) | Investor deck | 28 slides | Mar 30, 2020 |
| Investor Presentation (March 2020) | Investor deck | 26 slides | Mar 4, 2020 |
| Investor Presentation (November 2019) | Investor deck | 31 slides | Nov 14, 2019 |
| Corporate Update (August 2019) | Corporate update | 15 slides | Aug 14, 2019 |
| Investor Presentation (August 2019) | Investor deck | 34 slides | Aug 14, 2019 |
| Investor Presentation (May 2019) | Investor deck | 32 slides | May 9, 2019 |
| Investor Presentation (April 2019) | Investor deck | 32 slides | Apr 10, 2019 |
| FY2018 Earnings Presentation | Earnings | 27 slides | Mar 26, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Nancy J Hutson Other companies: BioCryst Pharmaceuticals, Inc. (Director · Since at least Jan 20, 2012); Clearside Biomedical Inc (Director · Apr 21, 2020 – Jun 20, 2024 · Past); Endo International PLC (Director · Feb 28, 2014 – Jun 11, 2021 · Past); Cubist Pharmaceuticals Inc (Director · Jun 12, 2008 – Jan 21, 2015 · Past); Inspire Pharmaceuticals Inc (Director · Oct 27, 2006 – May 13, 2011 · Past) | Director · Oct 17, 2018 – May 19, 2023 · Past |
| Caroline M Loewy Other companies: eFFECTOR Therapeutics Inc (Director · Sep 9, 2023 – Jun 13, 2024 · Past); CERo Therapeutics Holdings, Inc. (Director · Oct 5, 2021 – Feb 14, 2024 · Past); Zogenix Inc (Director · Sep 21, 2020 – Mar 7, 2022 · Past); Aptose Biosciences Inc (Director · Dec 21, 2018 – Jan 18, 2022 · Past) | Director · Oct 17, 2018 – May 19, 2023 · Past |
| Richard A. van den Broek Other companies: Corvus Pharmaceuticals, Inc. (Board Member · Since at least Apr 8, 2025); Pulse Biosciences, Inc (Director · Since at least Aug 6, 2020); Celldex Therapeutics, Inc. (Director · Dec 17, 2014 – Jun 8, 2016 · Past); Pharmacyclics Inc (Director · Oct 3, 2011 – May 26, 2015 · Past) | Director · Feb 27, 2019 – May 19, 2023 · Past |
| Tyrell J. Rivers Other companies: ADC Therapeutics SA (Non-Executive Director · Since at least Jan 2, 2024); Viela Bio Inc (Director · Oct 2, 2019 – Mar 15, 2021 · Past); G1 Therapeutics Inc (Director · May 16, 2017 – May 16, 2017 · Past) | Director · Oct 17, 2018 – Oct 17, 2018 · Past |
| Alex C. Sapir Other companies: Fulcrum Therapeutics, Inc. (President and Chief Executive Officer · Since at least Jul 1, 2023); Dova Pharmaceuticals Inc (President & CEO, Director · Jun 28, 2017 – Aug 14, 2018 · Past) | Director · Feb 12, 2020 – May 19, 2023 · Past |
| John P Sharp Other companies: Skye Bioscience, Inc. (Chief Financial Officer · Since at least Mar 31, 2026) | Chief Financial Officer · Oct 17, 2018 – May 20, 2022 · Past |
| Kristopher Hanson Other companies: MapLight Therapeutics, Inc. (General Counsel · Since at least Oct 25, 2025) | SVP and General Counsel · Nov 20, 2020 – May 20, 2022 · Past |
| Michael York Other companies: Metacrine Inc (Chief Business Officer · Feb 18, 2022 – Jan 26, 2023 · Past) | VP, Corporate Development · Oct 17, 2018 – May 20, 2021 · Past |
| Bibhash Mukhopadhyay | Director · Oct 17, 2018 – May 9, 2019 · Past |
| Glen Burkhardt | SVP of Human Resources · May 20, 2022 – May 20, 2022 · Past |
All 13 people
| Person | Seat |
|---|---|
| John Sang Lee | Chief Medical Officer · Oct 17, 2018 – Feb 24, 2022 · Past |
| Jonathan Birchall | Chief Commercial Officer · Nov 8, 2021 – May 20, 2022 · Past |
| Susan Elizabeth Arnold | SVP, Technical Operations · Oct 17, 2018 – May 20, 2022 · Past |
Log in to ask 6ix AI your own questions about PhaseBio Pharmaceuticals Inc.